Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Booster”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT07095231
What this trial is testing

Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 60
Testing effectiveness (Phase 2)WithdrawnNCT05254236
What this trial is testing

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd.
Post-approval studies (Phase 4)UnknownNCT06587503
What this trial is testing

Safety and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster Doses

Who this might be right for
Ebola Virus DiseaseCOVID-19
University of Birmingham 72
Not applicableStudy completedNCT05648773
What this trial is testing

COVID-19 Booster Incentives

Who this might be right for
Booster MessageBooster Message + Financial Incentive
University of Southern California 57,893
Early research (Phase 1)Study completedNCT05693272
What this trial is testing

A Clinical Trial to Study the COVAC-1 Booster Dose in Generally Healthy Adults

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
University of Saskatchewan 47
Large-scale testing (Phase 3)Study completedNCT05875701
What this trial is testing

Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines

Who this might be right for
COVID-19
Novavax 147
Not applicableStudy completedNCT05586165
What this trial is testing

Effects of Prompt to Bundle COVID-19 Booster and Flu Shot

Who this might be right for
COVID-19Vaccines
University of California, Los Angeles 109,493
Early research (Phase 1)Study completedNCT05226702
What this trial is testing

Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults.

Who this might be right for
Double Vaccinated for COVID-19 (For Phase 1 of the Study)Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group)
University of Saskatchewan 60
Very early researchUnknownNCT05918939
What this trial is testing

UNAIR Inactivated COVID-19 Vaccine as Heterologue Booster (Immunobridging Study)

Who this might be right for
COVID-19 PandemicCOVID-19 Vaccines
Dr. Soetomo General Hospital 350
Not applicableWithdrawnNCT05476822
What this trial is testing

Profiling Spike Protein Antibody Response Post COVID-19 Booster

Who this might be right for
COVID-19 BoosterSpike Protein IgG Antibody
David Grant U.S. Air Force Medical Center
Large-scale testing (Phase 3)Study completedNCT05246137
What this trial is testing

A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Hipra Scientific, S.L.U 2,646
Not applicableStudy completedNCT05438472
What this trial is testing

Incidence, Patient Characteristics and Outcome of Myocarditis After COVID-19 mRNA Vaccine

Who this might be right for
Myocarditis
University Hospital, Basel, Switzerland 835
Large-scale testing (Phase 3)Study completedNCT05501522
What this trial is testing

Immunogenicity and Safety Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine(GBP510) Adjuvanted with AS03 in Adults Aged 18 Years and Older

Who this might be right for
COVID-19
SK Bioscience Co., Ltd. 840
Not applicableStudy completedNCT06130410
What this trial is testing

Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years

Who this might be right for
SARS-CoV-2COVID-19
Pfizer 25
Not applicableStudy completedNCT05268185
What this trial is testing

The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19)

Who this might be right for
COVID-19Vaccine ReactionCOVID-19 Pandemic
University of California, San Francisco 301
Not applicableUnknownNCT05471440
What this trial is testing

SWITCH ON: Analysing the Immunogenicity of Additional Booster Vaccinations in HCW

Who this might be right for
Covid-19 Vaccination
Erasmus Medical Center 431
Very early researchUnknownNCT05583357
What this trial is testing

Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 40
Not applicableUnknownNCT05886790
What this trial is testing

A Clinical Trial on Booster Immunization of Two COVID-19 Vaccines Constructed From Different Technical Routes

Who this might be right for
COVID-19
Zhongnan Hospital 450
Large-scale testing (Phase 3)UnknownNCT05911087
What this trial is testing

A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2

Who this might be right for
ImmunogenicitySafety
Stemirna Therapeutics 800
Not applicableLooking for participantsNCT06168032
What this trial is testing

COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research

Who this might be right for
COVID-19 RecurrentLung CancerVaccination+3 more
Peking Union Medical College Hospital 1,224
Next Page